Global Intravitreal Injectables Market Report 2022: Rising Diabetes Prevalence Fuels Sector Growth – ResearchAndMarkets.com

DUBLIN-(BUSINESS WIRE)–The report “Intravitreal Injectables Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030” has been added to ResearchAndMarkets.com supply.

Industry forecast

The intravitreal injectables market will demonstrate steady growth at a compound annual growth rate (CAGR) of 4.8% during the forecast period 2022 to 2030.

According to statistics provided by the World Health Organization (WHO), an estimated 1.3 billion people worldwide suffer from some form of blindness, mainly caused by macular degeneration, diabetic retinopathy, ocular vein occlusions, endophthalmitis and retinitis. Intravitreal injections are preferred over other treatment options for disease-related visual impairment.

Rising prevalence of diabetes and increasing geriatric population are driving the growth

According to the study cited by the Lancet journal, the global prevalence of any age-related macular degeneration is 8.69%, with a higher prevalence rate in the Caucasian population, followed by Mongoloids. The main factors that increase the risk factor for the occurrence of macular degeneration are the increasing age population, smoking, obesity, genetics, diabetes, etc. Diabetic retinopathy is a secondary manifestation of the disease occurring in elderly people with a previous history of diabetes. Endophthalmitis is increasing at a faster rate due to increases in air and water pollution and eye trauma.

Excellent biocompatibility and impressive pharmacodynamic properties drive the anti-VEGF drug market

Anti-VEGF dominates the drug segment of the intravitreal injection market. Since their commercialization in 2006, drugs such as bevacizumab (Avastin), ranibizumab (Lucentis), etc. are considered first-line drug therapy in patients suffering from neovascular age-related macular degeneration and ocular vein occlusion.

Its inherent characteristics such as excellent biocompatibility and impressive pharmacodynamic properties have led to its increased popularity among ophthalmologists worldwide. Corticosteroids are used as adjuvant drug therapy to relieve inflammation caused by eye infections. Antifungal drugs and antibiotics are prescribed together for eye infections such as endophthalmitis and retinitis.

Rising prevalence of eye diseases and affordable reimbursement scenario are driving the growth of the intravitreal injectable products market

In the current situation, North America accounts for 37% market share in the regional segment for the intravitreal injectable products market. According to statistics provided by the Centers for Disease Control and Prevention (CDC), approximately 3.3 million Americans over the age of 40 are blind or have low vision. The increasing prevalence of eye diseases and the affordable reimbursement scenario are driving the growth of the market in North America. Europe accounts for 26% share owing to the presence of thriving healthcare infrastructure and the domicile of key players such as Novartis AG, Allergan, Inc., Alimera Sciences, F.Hoffman-La Roche Ltd. etc. drive market growth in Europe. Asia Pacific holds 20% market share and is keen to capture the regional market in the near future due to the favorable regulatory environment provided by health agencies and developing ophthalmic research centers ensuring optimal eye care.

The pharmaceutical giants competing to maintain their positions in the intravitreal injectable products market are Allergan, Inc., Genetech, Inc., Alimera Sciences, Bristol-Myers Squibb Company, Eyetech, Inc., F.Hoffman-La Roche Ltd. , Novartis AG, Regeneron Pharmaceuticals, Inc., ThromboGenics, Inc. and Valeant Pharmaceuticals International, Inc.

Market segmentation

Indication

  • Macular degeneration

  • Diabetic retinopathy

  • Retinal vein occlusions

  • Endophthalmitis

  • others

A class of drugs

  • Anti-VEGF

  • Corticosteroids

  • antibiotics

  • Antiviruses

  • Antifungal agents

Key questions answered in this report

  • What are the key micro and macro environmental factors impacting the growth of the Intravitreal Injectables market?

  • What are the key investment pockets in terms of product segments and geographies currently and during the forecast period?

  • Expected Forecast and Market Forecasts to 2030

  • Which segment reported the fastest CAGR during the forecast period?

  • Which market segment has the larger market share and why?

  • Are Low and Middle Income Economies Investing in the Intravitreal Injectables Market?

  • Which is the largest regional market for Intravitreal Injections market?

  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America and the Middle East and Africa?

  • What are the key trends driving the growth of the Intravitreal Injectables market?

  • Who are the key competitors and what are their key strategies to improve their market presence in the global intravitreal injectables market?

Main topics covered:

1. Preface

2. Summary

3. Intravitreal Injectables Market: Competitive Analysis

4. Intravitreal Injectables Market: Macro Analysis and Market Dynamics

5. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)

6. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)

7. North America Intravitreal Injectables Market, 2020-2030, USD (Million)

8. UK and EU Intravitreal Injectables Market, 2020-2030, USD (Million)

9. Asia-Pacific Intravitreal Injectables Market, 2020-2030, USD (Million)

10. Latin America Intravitreal Injectables Market, 2020-2030, USD (Million)

11. Middle East and Africa Intravitreal Injectables Market, 2020-2030, USD (Million)

12. Company Profile

The mentioned companies

  • Allergan Inc.

  • Genetech Inc.

  • Alimera Sciences

  • Bristol-Myers Squibb Company

  • Eyetech Inc.

  • F.Hoffman-La Roche Ltd.

  • Novartis AG

  • Regeneron Pharmaceuticals Inc.

  • ThromboGenics Inc.

  • Valeant Pharmaceuticals International Inc.

For more information on this report, visit https://www.researchandmarkets.com/r/aj8he9

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We bring you the latest data on international and regional markets, key industries, leading companies, new products and the latest trends.

Leave a Comment

Your email address will not be published. Required fields are marked *